Edition:
United States

People: Aldeyra Therapeutics Inc (ALDX.A)

ALDX.A on American Stock Exchange

5.42USD
18 Jul 2019
Change (% chg)

$-0.06 (-1.09%)
Prev Close
$5.48
Open
$5.42
Day's High
$5.42
Day's Low
$5.42
Volume
100
Avg. Vol
520
52-wk High
$16.55
52-wk Low
$5.01

McMullin, David 

Mr. David McMullin is Chief Commercial Officer of the company. he was Senior Vice President - Corporate Development and Strategy of the Company. Mr. McMullin brings extensive experience leading business development, strategic planning, commercial and operational activities in the biopharmaceutical industry. Prior to joining Aldeyra, Mr. McMullin most recently served as the Group Vice President of the$1.4 billionU.S. Internal Medicines franchise at Shire plc where he led sales, marketing, and business operations for the U.S. rare disease and specialty products business. Previously, he was Vice President of the Commercial Center of Excellence at Shire, responsible for commercial operations worldwide. Prior to joining Shire, Mr. McMullin was the Vice President of Global Supply Chain and Strategy at Novartis Vaccines and Diagnostics (now part of GlaxoSmithKline plc), where he led a successful operational turnaround followed by an asset swap divestiture between Novartis AG and GlaxoSmithKline plc. He also held management positions in marketing, sales, and corporate strategy at Novartis Pharmaceuticals and Novartis International, divisions of Novartis AG. Mr. McMullin received a Master of Business Administration degree from Harvard University, and a Bachelor of Science degree from Brigham Young University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --